Female infertility in the 21st century

Review OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-28 ⓘ

This review updates female infertility management by discussing common gynecologic causes like endometriosis and advances in assisted reproductive technology to support patient counseling and referrals.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-28 · read from full text ⓘ

This review article outlines the definition, epidemiology, and common gynecologic causes of female infertility in the United States, including tubal factors, ovulatory dysfunction, and diminished ovarian reserve. It details treatment modalities ranging from low-tech options like ovulation induction and intrauterine insemination to high-tech assisted reproductive technologies such as in vitro fertilization, noting that endometriosis is a significant cause of tubal obstruction and anatomical distortion. The text explicitly identifies endometriosis as a condition that can impair oocyte quality and hinder embryo implantation through adhesions and fibrosis. This paper is centrally about endometriosis — specifically its role as a common gynecologic cause of female infertility leading to tubal obstruction and impaired implantation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

More than 12% of reproductive-age women in the United States seek infertility services each year. Infertility is commonly defined as failure to conceive after 12 months of regular, unprotected sexual intercourse. Common gynecologic causes of female infertility include endometriosis; diminished ovarian reserve; ovulatory dysfunction and anovulation; and other cervical, uterine, or tubal factors. Advances in medicine and assisted reproductive technology have expanded treatment options for women and couples experiencing infertility. This article provides an updated review of female infertility to support PAs in delivering informed patient counseling on treatment options, recognizing potential complications, and facilitating timely and appropriate referrals.
Full text 36,898 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Conclusion

Female infertility is a complex medical condition, with approximately 12% of reproductive-age women in the US utilizing infertility services each year. With advances in medicine, especially in the field of ART, the options for individuals and couples seeking infertility services have expanded. PAs across disciplines should be knowledgeable in common infertility causes, along with ART procedures and their potential complications, in order to educate individuals and couples effectively, participate in shared decision-making, and treat and manage patients receiving infertility services appropriately.

References

1 Zegers-Hochschild F, Adamson GD, Dyer S, et alThe International Glossary on Infertility and Fertility Care, 2017†‡§. Hum Reprod. 2017;32(9):1786–1801. doi:10.1093/humrep/dex234.2 Teede HJ, Khomami MB, Morman R, et alPolyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329–2339. doi:10.1016/S0140-6736(26)00717-8.3 FastStats. March 17, 2025. Accessed December 23, 2025. https://www.cdc.gov/nchs/fastats/infertility.htm.4 NSFG - Listing I - Key Statistics from the National Survey of Family Growth. December 16, 2022. Accessed December 23, 2025. https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm.5 Phillips K, Olanrewaju RA, Omole F. Infertility: evaluation and management. Am Fam Physician. 2023;107(6):623–630.6 Vitale SG, De Angelis MC, Della Corte L, et alUterine cervical stenosis: from classification to advances in management. Overcoming the obstacles to access the uterine cavity. Arch Gynecol Obstet. 2024;309(3):755–764. doi:10.1007/s00404-023-07126-1.7 Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65–76. doi:10.1001/jama.2021.4788.8 Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. doi:10.1016/j.clinbiochem.2018.03.012.9 Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. doi:10.1002/ijgo.12666.10 Munro MG, Balen AH, Cho S, et alThe FIGO ovulatory disorders classification system. Int J Gynecol Obstet. 2022;159(1):1–20. doi:10.1002/ijgo.14331.11 Dieke AC, Zhang Y, Kissin DM, Barfield WD, Boulet SL. Disparities in assisted reproductive technology utilization by race and ethnicity, United States, 2014: a commentary. J Womens Health. 2017;26(6):605–608. doi:10.1089/jwh.2017.6467.12 Jain M, Singh M. Assisted Reproductive Technology (ART) Techniques. In: StatPearls. StatPearls Publishing; 2025. Accessed September 7, 2025. http://www.ncbi.nlm.nih.gov/books/NBK576409/.13 Zippl AL, Wachter A, Rockenschaub P, Toth B, Seeber B. Predicting success of intrauterine insemination using a clinically based scoring system. Arch Gynecol Obstet. 2022;306(5):1777–1786. doi:10.1007/s00404-022-06758-z.14 Kamel RM. Assisted reproductive technology after the birth of Louise Brown. J Reprod Infertil. 2013;14(3):96–109.15 Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion (2020). Accessed December 23, 2025. https://www.asrm.org/practice-guidance/practice-committee-documents/use-of-exogenous-gonadotropins-for-ovulation-induction-in-anovulatory-women-a-committee-opinion-2020/.16 Hilbert SM, Gunderson S. Complications of assisted reproductive technology. Emerg Med Clin North Am. 2019;37(2):239–249. doi:10.1016/j.emc.2019.01.005.17 Levi-Setti PE, Segni ND, Gargasole C, Ronchetti C, Cirillo F. Ovarian hyperstimulation: diagnosis, prevention, and management. Semin Reprod Med. 2021;39:170–179. doi:10.1055/s-0041-1736492.18 Timmons D, Montrief T, Koyfman A, Long B. Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med. 2019;37(8):1577–1584. doi:10.1016/j.ajem.2019.05.018.19 National Summary Report. Accessed May 14, 2026. https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=2022.20 Liu XM, Zhang F, Lu XS, Xi HT, Zhao JZ. Effects and safety of propofol intravenous anesthesia in transvaginal oocyte retrieval on outcomes of in vitro fertilization and embryo transplantation. Front Endocrinol. 2024;15: doi:10.3389/fendo.2024.1497948.21 Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11(3):307–311. doi:10.1097/00001703-199906000-00013.22 Grading Scales. Accessed May 14, 2026. https://www.asrm.org/asrm-academy/asrm-academy-on-the-go/embryo-data-grading--evaluation/grading-scales/.23 Preimplantation Genetic Testing. Accessed May 14, 2026. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/03/preimplantation-genetic-testing.24 ESHRE PGT Consortium Steering Committee, Carvalho F, Coonen E, et alESHRE PGT Consortium good practice recommendations for the organisation of PGT†. Hum Reprod Open. 2020;2020(3):hoaa021. doi:10.1093/hropen/hoaa021.25 Franasiak JM, Forman EJ, Hong KH, et alThe nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656–663.e1. doi:10.1016/j.fertnstert.2013.11.004.26 Consideration of the gestational carrier: an Ethics Committee opinion (2023). Accessed December 23, 2025. https://www.asrm.org/practice-guidance/ethics-opinions/consideration-of-the-gestational-carrier-an-ethics-committee-opinion-2023/.27 Richards EG, Farrell RM, Ricci S, et alUterus transplantation: state of the art in 2021. J Assist Reprod Genet. 2021;38(9):2251–2259. doi:10.1007/s10815-021-02245-7.28 Gestational Carrier Policy in the United States. Accessed May 14, 2026. https://www.asrm.org/advocacy-and-policy/fact-sheets-and-one-pagers/gestational-carrier-policy-in-the-united-states/.29 Leathersich S, Roche C, Hart R. Minimising OHSS in women with PCOS. Front Endocrinol. 2025;16: doi:10.3389/fendo.2025.1507857.30 Selter J, Wen T, Palmerola KL, Friedman AM, Williams Z, Forman EJ. Life-threatening complications among women with severe ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 2019;220(6):575.e1–575.e11. doi:10.1016/j.ajog.2019.02.009.31 Olchowy A, Olchowy C, Łasecki M, et alOvarian hyperstimulation syndrome as a growing diagnostic problem in emergency department settings: a case report. J Emerg Med. 2019;56(2):217–221. doi:10.1016/j.jemermed.2018.11.004.32 Adams A, Adams C. Ovarian hyperstimulation syndrome: a case report. J Emerg Nurs. 2023;49(1):8–11. doi:10.1016/j.jen.2022.09.006.33 Hsu JC, Huang KL, Tsai NC. Bilateral massive bloody pleural effusions as a rare presentation of ovarian hyperstimulation syndrome: a case report and literature review. Taiwan J Obstet Gynecol. 2025;64(2):348–352. doi:10.1016/j.tjog.2024.03.030.34 Koh H, Kim SD, Yang H. Ischemic stroke associated with ovarian hyperstimulation syndrome. J Emerg Med. 2021;61(3):320–324. doi:10.1016/j.jemermed.2021.05.001.35 Grandone E, Bitsadze V, Khizroeva J, et alRisk of thrombosis in women undergoing in vitro fertilization: a narrative review. J Clin Med. 2025;14(4):1053. doi:10.3390/jcm14041053.36 Elmahal M, Lohana P, Anvekar P, Menda MK, Arti. Hyponatremia: an untimely finding in ovarian hyper-stimulation syndrome. Cureus. 2021;13(7):e16556. doi:10.7759/cureus.16556.37 Khalil MAM, Ghazni MS, Tan J, Naseer N, Khalil MAU. Spontaneous bacterial peritonitis and anasarca in a female patient with ovarian hyperstimulation syndrome complicated by respiratory and kidney failure. Case Rep Gastroenterol. 2016;10(2):423–430. doi:10.1159/000446766.38 Misiriyyah N, Qurban K, Beevi A, Paulose L, Margossian H. Adnexal torsion associated with recurrent ovarian hyperstimulation syndrome: a case report. Cureus. 2023;15(3):e36344doi:10.7759/cureus.36344.39 Phillips CH, Wortman JR, Ginsburg ES, Sodickson AD, Doubilet PM, Khurana B. First-trimester emergencies: a radiologist’s perspective. Emerg Radiol. 2018;25(1):61–72. doi:10.1007/s10140-017-1556-9.40 Maleki A, Khalid N, Patel CR, El-Mahdi E. The rising incidence of heterotopic pregnancy: Current perspectives and associations with in-vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2021;266:138–144. doi:10.1016/j.ejogrb.2021.09.031.41 Trindade VD, Hentschke MR, Dornelles VC, et alTubal factor, cleavage stage and more than one embryo transferred were risk factors associated with ectopic pregnancy after assisted reproductive treatment. JBRA Assist Reprod. 2022;26(2):321–328. doi:10.5935/1518-0557.20210074.42 Zhu S, Fan Y, Lan L, Deng T, Zhang Q. Heterotopic pregnancy secondary to in vitro fertilization-embryo transfer: risk factors and pregnancy outcomes. Front Med. 2022;9:864560. doi:10.3389/fmed.2022.864560.43 Farren J, Al Wattar BH, Jurkovic D. The diagnosis and management of extrauterine and uterine ectopic pregnancy. Hum Reprod Update. 2026;32(1):2–32. doi:10.1093/humupd/dmaf024.44 Harzif AK, Hyaswicaksono P, Kurniawan RH, Wiweko B. Heterotopic pregnancy: diagnosis and pitfall in ultrasonography. Gynecol Minim Invasive Ther. 2021;10(1):53–56. doi:10.4103/GMIT.GMIT_92_19.45 Mullany K, Minneci M, Monjazeb R, Coiado CO. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health. 2023;19:17455057231160349. doi:10.1177/17455057231160349.46 Chen L, Zhang H, Xu Y, Wang Z. Intra-abdominal hemorrhage following ultrasound-guided transvaginal oocyte retrieval: retrospective analysis of 25 cases. AJOG Glob Rep. 2025;5(3):100508. doi:10.1016/j.xagr.2025.100508.47 Stojnic J, Bila J, Tulic L, et alSevere hemoperitoneum due to ovarian bleeding after transvaginal oocyte retrieval with surgical management: a retrospective analysis and comprehensive review of the literature. Medicina (Mex). 2023;59(2):307. doi:10.3390/medicina59020307.48 Ghasemian Dizaj Mehr S, Bahadori R. Successful conservative management of massive hemoperitoneum in patients on anticoagulation with ruptured hemorrhagic ovarian cyst: a report of two cases and review of literature. J Obstet Gynecol Cancer Res. 2024;9(2):231–234. doi:10.30699/jogcr.9.2.231.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female Infertility, Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-17T06:10:42.428116+00:00
pubmed
last seen: 2026-11-17T06:04:02.938873+00:00
unpaywall
last seen: 2026-11-17T06:36:55.820963+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine